Relief From Painful Bone Mets Possible at Day 10 of Radiotherapy
Men with painful bone metastases from prostate cancer may be able to achieve clinically meaningful improvements in pain and quality of life as early as 10 days after undergoing radiotherapy.
Frontline CLL Therapy: Changes in Paradigm
Significant progress has been made in the treatment of chronic lymphocytic leukemia with the addition of options such as the tyrosine kinase inhibitor ibrutinib, the monoclonal antibody obinutuzumab, and the BCL2 inhibitor venetoclax.
Overview of Myeloproliferative Disorders
In this interview we discuss clinical developments in essential thrombocythemia, polycythemia vera, and myelofibrosis, as well as the latest treatment options.
Clofarabine Consolidation May Improve RFS in Younger AML Patients
Three courses of clofarabine combined with cytarabine may improve relapse-free survival in patients with acute myeloid leukemia in first remission.
Smoking Worsens Prognosis for Patients With CML
Smoking is linked to mortality and to disease progression among patients with chronic myeloid leukemia.
New Options for Treating AL Amyloidosis
New treatment options are now available for light-chain amyloidosis, with additional ones on the way, according to a presentation at the 21st Annual International Congress on Hematologic Malignancies.
Feasible for Patients to Self-Report Adverse Events in Clinical Trials
Patients participating in cancer clinical trials were willing and able to report symptomatic adverse events and reported more events than investigators did.
Right Upper Quadrant Pain in Abdomen of 60-Year-Old Patient
A 60-year-old woman presents with vague abdominal pain in the right upper quadrant. An ultrasound reveals a gallbladder abnormality. Based on the images from the abdomen MRI, what is the diagnosis?
Pineal Mass Discovered in 2-Year-Old Child
A 2-year-old child is found to have a pineal mass, and a biopsy is performed. What is your diagnosis?
Does Active Surveillance Benefit Patients With Metastatic RCC?
Active surveillance prior to initiating targeted therapy might benefit patients with metastatic renal cell carcinoma, since it delays therapy and toxicities.
By clicking Accept, you agree to become a member of the UBM Medica Community.